Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Pentamidine isethionate
Drug ID BADD_D01718
Description Antiprotozoal agent effective in trypanosomiasis, leishmaniasis, and some fungal infections; used in treatment of pneumocystis pneumonia in HIV-infected patients. It may cause diabetes mellitus, central nervous system damage, and other toxic effects.
Indications and Usage For the treatment of pneumonia due to Pneumocystis carinii.
Marketing Status Prescription; Discontinued
ATC Code P01CX01
DrugBank ID DB00738
KEGG ID D00834
MeSH ID D010419
PubChem ID 8813
TTD Drug ID D05EAM
NDC Product Code 23155-748; 39822-3050; 13925-515; 14593-930; 11712-790; 11712-788; 63323-113; 13925-522; 63323-877
Synonyms Pentamidine | Pentamidin | Lomidine | NebuPent | Pentamidine Isethionate | Pentam | Pentamidine Mesylate | Diamidine | Pentacarinat
Chemical Information
Molecular Formula C19H24N4O2.2C2H6O4S
CAS Registry Number 140-64-7
SMILES C1=CC(=CC=C1C(=N)N)OCCCCCOC2=CC=C(C=C2)C(=N)N.C(CS(=O)(=O)O)O.C(CS(=O)(=O)O)O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Paranoia19.05.01.005--Not Available
Phlebitis24.05.03.001; 12.02.01.002--
Pleurisy22.05.01.001--Not Available
Pneumothorax22.05.02.003--
Pruritus23.03.12.001--
Rales22.02.04.004--Not Available
Rash23.03.13.001--Not Available
Renal failure20.01.03.005--Not Available
Retching07.01.07.002--Not Available
Rhinitis22.07.03.006; 11.01.13.004--
Salivary hypersecretion07.06.01.009--Not Available
Seizure17.12.03.001--
Skin exfoliation23.03.07.003--Not Available
Somnolence17.02.04.006; 19.02.05.003--
Splenomegaly01.09.02.001--Not Available
Stevens-Johnson syndrome23.03.01.007; 12.03.01.014; 11.07.01.005; 10.01.03.020--
Syncope24.06.02.012; 17.02.04.008; 02.01.02.008--
Tachycardia02.03.02.007--Not Available
Tachypnoea22.02.01.014--Not Available
Thrombocytopenia01.08.01.002--Not Available
Torsade de pointes02.03.04.005--Not Available
Tremor17.01.06.002--
Urticaria23.04.02.001; 10.01.06.001--
Vasculitis10.02.02.006; 24.05.02.001--
Vasodilatation24.03.02.003; 23.06.05.006--Not Available
Ventricular tachycardia02.03.04.010--
Vertigo17.02.12.002; 04.04.01.003--
Vision blurred17.17.01.010; 06.02.06.007--
Vomiting07.01.07.003--
Respiratory tract congestion22.02.07.003--Not Available
The 4th Page    First    Pre   4 5    Next   Last    Total 5 Pages